Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Mar 4;9(1):e003045.
doi: 10.1136/bmjpo-2024-003045.

Impact of probiotic supplements on behavioural and gastrointestinal symptoms in children with autism spectrum disorder: A randomised controlled trial

Affiliations
Randomized Controlled Trial

Impact of probiotic supplements on behavioural and gastrointestinal symptoms in children with autism spectrum disorder: A randomised controlled trial

Himani Narula Khanna et al. BMJ Paediatr Open. .

Abstract

Objective: To investigate whether probiotic supplementation can improve behavioural and gastrointestinal (GI) symptoms in children with autism spectrum disorder (ASD) aged 2-9 years and further explore the correlation between these symptoms.

Design: Single-blinded, randomised, placebo-controlled study.

Setting: Five developmental paediatric outpatient clinics of 'Continua Kids'.

Patients: Children aged 2-9 years diagnosed with ASD along with their caregivers.

Interventions: Probiotic or placebo sachet reconstituted in 50 mL of lukewarm milk/water, taken two times per day for 3 months.

Main outcome measures: Change in behavioural (measured by Social Responsiveness Scale-2 (SRS-2) and Aberrant Behaviour Checklist-2 (ABC-2) tools) and GI (measured by GI Severity Index (GSI) score) symptoms after receiving intervention for 3 months.

Results: A total of 180 children with ASD were enrolled in the study (probiotic group: 90 and placebo group: 90). All children completed the study. The probiotic group showed a significant reduction in behavioural symptom severity as measured by the SRS-2 tool (47.77% vs 23.33%; p=0.000) compared with the placebo. Probiotic-treated children demonstrated significant reductions in severe symptoms, including social withdrawal/lethargy (40%), stereotypic behaviour (37.77%), hyperactivity (34.44%) and inappropriate speech (32.22%) post-intervention (p=0.000). They also had marked improvements in constipation (p=0.003) and diarrhoea (p=0.043) compared with the placebo group. Both groups exhibited a statistically significant correlation between behavioural and GI symptoms.

Conclusions: Probiotic supplementation improved behavioural and GI symptoms in children with ASD with no adverse effects. Both symptoms were significantly correlated. However, these results need to be validated in a larger sample size.

Trial registration number: CTRI/2021/11/038213.

Keywords: Child Health; Child Psychiatry; Neurology; Statistics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: No, there are no competing interests.

Figures

Figure 1
Figure 1. Change in behavioural symptoms assessed by SRS-2 T scores after intervention. RRBI, restricted repetitive behaviours and interests; SCI, social communication and interaction; SRS-2, Social Responsiveness Scale-2.
Figure 2
Figure 2. Change in behavioural characteristics assessed by ABC-2 scores after intervention. ABC-2, Aberrant Behaviour Checklist-2.
Figure 3
Figure 3. Change in GI symptoms assessed by GI scores after intervention. GI, gastrointestinal; GSI, GI Severity Index.

References

    1. Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6:5. doi: 10.1038/s41572-019-0138-4. - DOI - PMC - PubMed
    1. Zhuang H, Liang Z, Ma G, et al. Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy. MedComm (2020) 2024;5:e497. doi: 10.1002/mco2.497. - DOI - PMC - PubMed
    1. Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9:S55–65. doi: 10.21037/tp.2019.09.09. - DOI - PMC - PubMed
    1. Salari N, Rasoulpoor S, Rasoulpoor S, et al. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital J Pediatr. 2022;48:112. doi: 10.1186/s13052-022-01310-w. - DOI - PMC - PubMed
    1. Al-Beltagi M, Saeed NK, Bediwy AS, et al. Role of gastrointestinal health in managing children with autism spectrum disorder. World J Clin Pediatr. 2023;12:171–96. doi: 10.5409/wjcp.v12.i4.171. - DOI - PMC - PubMed

Publication types

LinkOut - more resources